NAV
$45.94
AUM
$5.8B
Expense Ratio
-
Dividend Yield
2.54%
Beta
0.87
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.81% | +2.90% | +5.79% | +17.71% | +16.80% | +8.64% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.09% |
| 2 | FTOXX | Goldman Sachs FS Treasury Obligs Instl | 1.06% |
| 3 | HSBA.L | HSBC Holdings PLC | 1.05% |
| 4 | RY | Royal Bank of Canada | 1.05% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 1.01% |
| 6 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.00% |
| 7 | AZN.L | AstraZeneca PLC | 0.87% |
| 8 | SAN.MC | Banco Santander SA | 0.79% |
| 9 | TD | The Toronto-Dominion Bank | 0.77% |
| 10 | 6857.T | Advantest Corp | 0.76% |
The index is designed to deliver exposure to equity securities of developed market issuers outside of the United States. The fund invests at least 80% of its assets (exclusive of collateral held from securities lending) in securities included in its underlying index, in depositary receipts representing securities included in its underlying index and in underlying stocks in respect of depositary receipts included in its underlying index.
Inception Date: 2015-11-06